Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical adalimumab (Humira) for chronic venous stasis ulcers
2009-015749-22Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Sep 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adalimumab in stasis ulcer, sponsored by Leipzig University. Primary endpoint: Reduction of wound area. Started Sep 2010; status: completed.
02
Drugs
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on 2009-015749-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015749-22.